| CLINUVEL PHARMACEUTICALS |
| Australien |
| Gesundheit |
| AU000000CUV3 / A0JEGY |
| UR9 (Frankfurt) |
| FRA:UR9, ETR:UR9, UR9:GR |
| - |
| https://www.clinuvel.com |
|
Clinuvel Pharmaceuticals Ltd is a global specialty biotechnology company dedicated to the development and commercialization of innovative treatments for rare and severe medical conditions. The company focuses particularly on disorders related to ligh..
>Volltext.. |
| 311.76 Mio. EUR |
| 179.55 Mio. EUR |
| 56.17 Mio. EUR |
| 22.75 Mio. EUR |
| 18.98 Mio. EUR |
| 0.38 EUR |
| 0.19 Mio. EUR |
| 21.08 Mio. EUR |
| 23.6 Mio. EUR |
| 13.05 |
| -0.02% |
| -20.23% |
| 0.03 EUR |
| 0.49% |
| 0.51% |
| 04.09.25 - 0.027875€ 05.09.24 - 0.027875€ >weitere anzeigen... |
| - |
| CLINUVEL |
| 21.07.26 |
|
||||
|